(Total Views: 430)
Posted On: 02/04/2019 1:41:39 AM
Post# of 154874
re Model-Update Progress: done
https://finesand.wordpress.com/cytodyns-pro-1...ion-model/
Other notable edits in above article
- THERF forward P/E > 23 today
- CYDY Combo Market-Size is more than 80 times of THERF’s Combo value in USD
- CYDY has Mono, GvHD and Cancer in pipeline, with Mono having 4x market-size of Combo
- R&R used a 24% royalty partnership in their model and if applied to HIV-1 Combo and Monotheraphy’s $46/sh we would end up at $11/sh roughly.
PDF https://cdn.discordapp.com/attachments/282295...dy-03b.pdf
ODS https://cdn.discordapp.com/attachments/282295...dy-03b.ods
https://finesand.wordpress.com/cytodyns-pro-1...ion-model/
Other notable edits in above article
- THERF forward P/E > 23 today
- CYDY Combo Market-Size is more than 80 times of THERF’s Combo value in USD
- CYDY has Mono, GvHD and Cancer in pipeline, with Mono having 4x market-size of Combo
- R&R used a 24% royalty partnership in their model and if applied to HIV-1 Combo and Monotheraphy’s $46/sh we would end up at $11/sh roughly.
PDF https://cdn.discordapp.com/attachments/282295...dy-03b.pdf
ODS https://cdn.discordapp.com/attachments/282295...dy-03b.ods
(0)
(1)
